(19)
(11) EP 4 135 852 A1

(12)

(43) Date of publication:
22.02.2023 Bulletin 2023/08

(21) Application number: 21788164.8

(22) Date of filing: 13.04.2021
(51) International Patent Classification (IPC): 
A61P 37/00(2006.01)
A61P 37/06(2006.01)
A61K 39/00(2006.01)
C12N 15/861(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 37/00; A61P 37/06; A61K 39/0008; A61K 2039/53; A61K 2039/577; C12N 2750/14143; C12N 2830/008; A61K 48/0058; A01K 2207/10; A01K 2227/105; A01K 2267/0368; A01K 2267/0356
(86) International application number:
PCT/US2021/027167
(87) International publication number:
WO 2021/211640 (21.10.2021 Gazette 2021/42)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.04.2020 US 202063010028 P

(71) Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Gainesville, FL 32611-5500 (US)

(72) Inventor:
  • HOFFMAN, Brad, E.
    Gainesville, FL 32606 (US)

(74) Representative: Potter Clarkson 
Chapel Quarter Chapel Bar
Nottingham NG1 6HQ
Nottingham NG1 6HQ (GB)

   


(54) ENHANCED EFFECTS OF GENE-IMMUNOTHERAPY AND IMMUNOSUPPRESSANTS IN MULTIPLE SCLEROSIS